Kathryn E. Wengel - 09 Nov 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role: EVP, Chief GSC Officer
Signature: Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel
Issuer symbol: JNJ
Transactions as of: 09 Nov 2022
Net transactions value: -$1,655,392
Form type: 4
Filing time: 10 Nov 2022, 15:47:13 UTC
Previous filing: 14 Jun 2022
Next filing: 09 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JNJ	Common Stock	Options Exercise	$1,190,381	+16,410	+23%	$72.54	87,721	09 Nov 2022	Direct
transaction	JNJ	Common Stock	Sale	$2,845,773	-16,410	-19%	$173.42	71,311	09 Nov 2022	Direct	F1
holding	JNJ	Common Stock						52	09 Nov 2022	By 401k	F2
holding	JNJ	Common Stock						281	09 Nov 2022	By ESOP	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JNJ	Employee Stock Options (Right to Buy)	Options Exercise	$0	-16,410	-100%	$0.000000^*	0	09 Nov 2022	Common Stock	16,410	$72.54	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $173.41 to $173.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2	Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2022).
F3	Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2022).